PMLS Virtual Series – Precision Diagnostics

Unable to attend? On Demand Here

September 24-25, 2020

Lori Anderson

Lori Anderson

Senior Product Manager, VisualStrata, XIFIN, Inc.

Chief Executive Officer & Co-Founder, CancerIQ

Feyi Olopade Ayodele, MBA

Chief Executive Officer and Co-Founder, CancerIQ

Senior Director, Pharmacodiagnostics, Bristol-Myers Squibb

Jonathan Baden

Senior Director, Pharmacodiagnostics, Bristol-Myers Squibb

Holly Bauzon

Holly Bauzon

Vice President Commercial Development, Microba

Parker Cassady, MBA

Parker Cassidy, MBA

Principal, Diagnostics and Tools, RA Capital Management, LP

Patricia Goede, PhD, MS

Patricia, Goede, PhD, MS

Vice President, Clinical Informatics, XIFIN, Inc.

Martyn Gross, MBA

Chief Business Officer, Mindera

Mark D. Hiatt, MD, MBA, MS

Mark D. Hiatt, MD, MBA, MS

Vice President, Medical Affairs, Guardant Health

Christiana Iyasere, MD, MBA

Christiana Iyasere, MD, MBA

Director, Massachusetts General Hospital Department of Medicine Innovation Program & Co-Founder, Dyrnamix, Inc

Eugean Jiwanmall, MBA, MPH

Eugean Jiwanmall, MBA, MPH

Senior Research Analyst, Medical Policy & Technology Evaluation, Independence Blue Cross

Jeff June

Jeff June

Chief Executive Officer & Founder, Ischemia Care

Luis Lasalvia, MD

Luis Lasalvia, MD, MIB

Vice President & Global Medical Officer, Siemens Healthineers

E. Jerome Madison

E. Jerome Madison

Vice President Provider Relations, Trapelo Health

Hannah Mamuszka

Hannah Mamuszka

Chief Executive Officer & Founder, Alva10

Robert Metcalf, MBA

Robert Metcalf, MBA

Chief Executive Officer, Concert Genetics; Adjunct Professor, Vanderbilt University

Satabhisa Mukhopadhyay, PhD, MS,

Satabhisa Mukhopadhyay, PhD, MS

Chief Scientific Officer & Founder, 4DPath

Bruce Quinn, MD, PhD

Bruce Quinn, MD, PhD

Principal, Bruce Quinn Associates LLC

Andy Riemer, EdM

Andy Riemer, EdM

Associate, SidePorch

Nancy Zhang, MD

Nancy Zhang, MD

Associate Director, Pharmacodiagnostics, Bristol-Myers Squibb